Correvio Pharma Corp (CORV) Forecast, Price Target & Analyst Ratings

NASDAQ:CORV

0.4199
+0 (+0.82%)
At close: May 26, 2020
0.4197
0 (-0.05%)
After Hours: 5/26/2020, 8:05:05 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Correvio Pharma Corp (CORV).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A

Next Earnings Forecast

Earnings Estimate
Release DateN/A

ChartMill Buy Consensus

Rating
60.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of $0.42 to mean target of N/A, Based on 3 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

 → Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CORV Current Analyst RatingCORV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

CORV Historical Analyst RatingsCORV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -17 -15 -13 -11 -9 -7 -5 -3 -1 1 2 3 4

Analyst Ratings Consensus

ChartMill Buy Consensus
60.00%
CORV was analyzed by 3 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about CORV.
In the previous month the buy percentage consensus was at a similar level.
Only 3 analysts analyzed CORV. So this is just the average opinion of a couple of analysts.
 → Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release DateN/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Correvio Pharma Corp / CORV Forecast FAQ

Can you provide the consensus rating for Correvio Pharma Corp stock?

The consensus rating for Correvio Pharma Corp (CORV) is 60 / 100 . This indicates that analysts generally have a neutral outlook on the stock.